| Antidepressant Medication Management |
CMS128v13 |
Not Applicable
|
009
|
MIPS, MVP |
M1369 |
Yes |
|
|
| Appropriate Testing for Pharyngitis |
CMS146v13 |
Not Applicable
|
066
|
MIPS |
|
Yes |
|
|
| Appropriate Treatment for Upper Respiratory Infection (URI) |
CMS154v13 |
Not Applicable
|
065
|
MIPS, MVP |
G0057, M1368 |
Yes |
|
|
| Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy |
CMS645v8 |
Not Applicable
|
462
|
MIPS, MVP |
M0001, M1423 |
Yes |
|
|
| Breast Cancer Screening |
CMS125v13 |
Not Applicable
|
112
|
APP Plus, MVP |
M1366 |
Yes |
|
|
| Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery |
CMS133v13 |
0565e
|
191
|
MIPS, MVP |
M1420 |
No |
|
|
| Cervical Cancer Screening |
CMS124v13 |
Not Applicable
|
309
|
MIPS, MVP |
M1366 |
Yes |
|
|
| Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment |
CMS177v13 |
Not Applicable
|
382
|
MIPS, MVP |
M1369 |
Yes |
|
|
| Childhood Immunization Status |
CMS117v13 |
Not Applicable
|
240
|
MIPS, MVP |
M1368 |
Yes |
|
|
| Children Who Have Dental Decay or Cavities |
CMS75v13 |
Not Applicable
|
378
|
MIPS |
|
No |
|
|
| Chlamydia Screening in Women |
CMS153v13 |
Not Applicable
|
310
|
MIPS, MVP |
M1366, M1368 |
Yes |
|
|
| Closing the Referral Loop: Receipt of Specialist Report |
CMS50v13 |
Not Applicable
|
374
|
MIPS, MVP |
M1420, M1422 |
Yes |
|
|
| Colorectal Cancer Screening |
CMS130v13 |
Not Applicable
|
113
|
MVP |
M1422 |
Yes |
|
Only used as part of the MVP reporting and not for traditional MIPS |
| Controlling High Blood Pressure |
CMS165v13 |
Not Applicable
|
236
|
MIPS, APP, APP Plus, MVP |
G0054, M0002, M0005 |
Yes |
|
|
| Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%) |
CMS145v13 |
0070e
|
007
|
MIPS, MVP |
G0055 |
Yes |
|
|
| Dementia: Cognitive Assessment |
CMS149v13 |
2872e
|
281
|
MIPS, MVP |
M0004 |
Yes |
|
|
| Depression Remission at Twelve Months |
CMS159v13 |
0710e
|
370
|
MIPS, MVP |
M1369 |
Yes |
|
|
| Diabetes: Eye Exam |
CMS131v13 |
Not Applicable
|
117
|
MIPS, MVP |
M1420 |
Yes |
|
|
| Diabetes: Glycemic Status Assessment Greater Than 9% |
CMS122v13 |
Not Applicable
|
001
|
MIPS, APP, APP Plus, MVP |
M0002, M0005 |
Yes |
|
|
| Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care |
CMS142v13 |
Not Applicable
|
019
|
MIPS, MVP |
M1420 |
No |
|
|
| Documentation of Current Medications in the Medical Record |
CMS68v14 |
Not Applicable
|
130
|
MIPS, MVP |
G0053, M0002, M0004, M1368, M1420, M1421, M1422 |
Yes |
|
|
| Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level) |
CMS1056v2 |
3633e
|
494
|
MIPS |
|
No |
|
Beginning with the Calendar Year 2025 performance period, hospitals and clinicians who choose to report this eCQM may use any vendor’s software that meets the necessary requirements to generate the standardized data elements required to calculate the measure, consistent with the measure’s specifications. Hospitals and clinicians are not required to use the Alara Imaging Software for CMS measure compliance. Any software vendor capable of calculating and reporting this eCQM in accordance with the measure’s specifications, including transforming radiology data into a format compatible with eCQM reporting, may report this measure on behalf of hospitals and clinicians. Hospitals and clinicians are not required to demonstrate to CMS that the software they or their vendors use can generate and transform the radiology data into the necessary format. However, nothing would prevent a hospital or clinician seeking assurance about the ability of specific software to perform these tasks from requesting that information from a vendor. As with all eCQMs, CMS will monitor measure results to ensure that all reported data for the Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults eCQM are both reliable and valid. This may include analyzing data to identify outliers and common characteristics of outlier submissions. Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography in Adults eCQM-Measure Clarification |
| Falls: Screening for Future Fall Risk |
CMS139v13 |
Not Applicable
|
318
|
MIPS, MVP |
M1423 |
Yes |
|
|
| Follow-Up Care for Children Prescribed ADHD Medication (ADD) |
CMS136v14 |
Not Applicable
|
366
|
MIPS, MVP |
M1369 |
Yes |
|
|
| Functional Status Assessment for Total Hip Replacement |
CMS56v13 |
Not Applicable
|
376
|
MIPS, MVP |
G0058 |
Yes |
|
|
| Functional Status Assessments for Heart Failure |
CMS90v14 |
Not Applicable
|
377
|
MIPS, MVP |
G0055 |
Yes |
|
|
| Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
CMS135v13 |
0081e
|
005
|
MIPS, MVP |
G0055 |
Yes |
|
|
| Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
CMS144v13 |
0083e
|
008
|
MIPS, MVP |
G0055 |
Yes |
|
|
| HIV Annual Retention in Care |
CMS1157v1 |
Not Applicable
|
340
|
MIPS, MVP |
M1368 |
Yes |
|
|
| HIV Screening |
CMS349v7 |
Not Applicable
|
475
|
MIPS, MVP |
M0005, M1366, M1368 |
Yes |
|
|
| HIV Viral Suppression |
CMS314v2 |
Not Applicable
|
338
|
MIPS, MVP |
M1368 |
Yes |
|
|
| Initiation and Engagement of Substance Use Disorder Treatment |
CMS137v13 |
Not Applicable
|
305
|
MIPS, MVP |
M0005, M1369 |
Yes |
|
|
| Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer |
CMS646v5 |
Not Applicable
|
481
|
MIPS, MVP |
M1423 |
No |
|
|
| Kidney Health Evaluation |
CMS951v3 |
Not Applicable
|
488
|
MIPS, MVP |
M0002 |
Yes |
|
|
| Oncology: Medical and Radiation - Pain Intensity Quantified |
CMS157v13 |
0384e
|
143
|
MIPS, MVP |
M0001 |
Yes |
|
|
| Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
CMS69v13 |
Not Applicable
|
128
|
MVP |
G0055, G0058, M1367, M1370, M1424 |
No |
|
Only used as part of the MVP reporting and not for traditional MIPS |
| Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
CMS2v14 |
Not Applicable
|
134
|
MIPS, APP, APP Plus, MVP |
G0053, G0055, M0001, M0005, M1366, M1368, M1369 |
Yes |
|
|
| Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented |
CMS22v13 |
Not Applicable
|
317
|
MIPS |
|
No |
|
|
| Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
CMS138v13 |
Not Applicable
|
226
|
MIPS, MVP |
M1366, M1367, M1420, M1421, M1422, M1424, M1425 |
Yes |
|
|
| Primary Caries Prevention Intervention as Offered by Dentists |
CMS74v14 |
Not Applicable
|
379
|
MIPS |
|
No |
|
|
| Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation |
CMS143v13 |
0086e
|
012
|
MIPS, MVP |
M1420 |
No |
|
|
| Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients |
CMS129v14 |
Not Applicable
|
102
|
MIPS, MVP |
M0001 |
No |
|
|
| Sexually Transmitted Infection (STI) Testing for People with HIV |
CMS1188v2 |
3755e
|
205
|
MIPS, MVP |
M1368 |
Yes |
|
|
| Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
CMS347v8 |
Not Applicable
|
438
|
MIPS, MVP |
G0054, M0005 |
Yes |
|
|
| Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia |
CMS771v6 |
Not Applicable
|
476
|
MIPS, MVP |
M1423 |
No |
|
|
| Use of High-Risk Medications in Older Adults |
CMS156v13 |
Not Applicable
|
238
|
MIPS, MVP |
G0055, M0004 |
Yes |
|
|
| Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents |
CMS155v13 |
Not Applicable
|
239
|
MIPS |
|
Yes |
|
|